Spots Global Cancer Trial Database for mouth neoplasms
Every month we try and update this database with for mouth neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative | NCT05774483 | Mouth Neoplasms | Sentinel Node B... Limited Electiv... | 18 Years - 80 Years | Tata Memorial Hospital | |
GDF15 Based TPF Induction Chemotherapy for OSCC Patients | NCT02285530 | Mouth Neoplasms Carcinoma, Squa... | TPF induction c... surgery group Post-operative ... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
A New Membrane Obturator Prothesis Concept for Soft Palate Defects | NCT04009811 | Mouth Neoplasms Velopharyngeal ... Speech Disorder... Deglutition Dis... | Suersen and mem... | 18 Years - | University Hospital, Bordeaux | |
Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals | NCT06231537 | Mouth Neoplasms | Visual oral exa... | 35 Years - 120 Years | Universidade Federal do Rio de Janeiro | |
Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity | NCT02604121 | Mouth Neoplasms | Orcellex® Rover... | 20 Years - | University Hospital, Toulouse | |
Polarized Reflectance Spectroscopy for Oral Lesions | NCT01604759 | Oral Cancer | Polarized Refle... | 18 Years - | British Columbia Cancer Agency | |
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity | NCT00953849 | Mouth Neoplasms | Celecoxib Calcitriol Celecoxib plus ... | 18 Years - 85 Years | VA Office of Research and Development | |
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | NCT00721799 | Mouth Neoplasms Oropharyngeal N... Laryngeal Neopl... Head and Neck N... | 18F-Fluorothymi... | 18 Years - | University of Iowa | |
Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) | NCT05296941 | Mouth Neoplasms | Brush sampling | 18 Years - | Dalarna County Council, Sweden | |
Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer | NCT05049408 | Oral Squamous C... | MMP-1 Enzyme Li... | 20 Years - | S&T Biomed Co., Ltd. | |
Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers | NCT03923998 | Squamous Cell C... | Neoadjuvant che... Neoadjuvant rad... Resection and r... | 18 Years - 70 Years | Indrayani Hospital and Cancer Institute | |
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer | NCT01553851 | Neoplasms, Oral Mouth Neoplasms | GSK1120212 | 18 Years - | Washington University School of Medicine | |
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer | NCT00272181 | Squamous Cell C... Carcinoma, Squa... Neoplasms, Squa... Head and Neck N... Mouth Neoplasms Head and Neck C... | Proxinium | 18 Years - | Sesen Bio, Inc. | |
Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) | NCT05296941 | Mouth Neoplasms | Brush sampling | 18 Years - | Dalarna County Council, Sweden | |
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients | NCT00721799 | Mouth Neoplasms Oropharyngeal N... Laryngeal Neopl... Head and Neck N... | 18F-Fluorothymi... | 18 Years - | University of Iowa | |
Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer | NCT01216020 | Head and Neck N... Laryngeal Neopl... Mouth Neoplasms Pharyngeal Neop... | cetuximab cisplatin (asso... | 18 Years - | Azienda USL 4 Prato | |
Polarized Reflectance Spectroscopy for Oral Lesions | NCT01604759 | Oral Cancer | Polarized Refle... | 18 Years - | British Columbia Cancer Agency | |
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage | NCT02290145 | Mouth Neoplasms Carcinoma, Squa... | TPF group surgery group Post-operative ... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma | NCT01195922 | Mouth Neoplasms Head and Neck N... Tongue Neoplasm... Carcinoma, Squa... | Sirolimus | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
The Feasibility Study of Dual-Section Nasogastric Tube | NCT01649349 | Stroke Mouth Neoplasms | two-piece nasog... | 20 Years - 80 Years | Changhua Christian Hospital | |
The Feasibility Study of Dual-Section Nasogastric Tube | NCT01649349 | Stroke Mouth Neoplasms | two-piece nasog... | 20 Years - 80 Years | Changhua Christian Hospital | |
Biomarkers for Oral Cancer | NCT00341497 | Lichen Planus Oral Leukoplaki... Mouth Neoplasms | 18 Years - 110 Years | National Institutes of Health Clinical Center (CC) | ||
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma | NCT01195922 | Mouth Neoplasms Head and Neck N... Tongue Neoplasm... Carcinoma, Squa... | Sirolimus | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity | NCT00953849 | Mouth Neoplasms | Celecoxib Calcitriol Celecoxib plus ... | 18 Years - 85 Years | VA Office of Research and Development | |
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer | NCT00272181 | Squamous Cell C... Carcinoma, Squa... Neoplasms, Squa... Head and Neck N... Mouth Neoplasms Head and Neck C... | Proxinium | 18 Years - | Sesen Bio, Inc. | |
Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer | NCT05049408 | Oral Squamous C... | MMP-1 Enzyme Li... | 20 Years - | S&T Biomed Co., Ltd. | |
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients | NCT02285543 | Mouth Neoplasms Carcinoma, Squa... | TPF induction c... surgery radiotherapy | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients | NCT02285543 | Mouth Neoplasms Carcinoma, Squa... | TPF induction c... surgery radiotherapy | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine |